Crato was elected during the General Assembly of the EHC 2023 Conference in Zagreb, Croatia this October. He brings a wealth of knowledge and experience to the organization, which he will leverage over his mandate.
Miguel Crato has hemophilia A with inhibitors and factor VII deficiency. He has been a member of the EHC Steering Committee since election in 2016, and is also a member of the EHC Inhibitor Working Group (IWG). He was also previously a member of the European Rare and Inhibitors Network (ERIN). Crato was President of the Associação Portuguesa de Hemofilia e de outras Coagulopatias Congénitas—the Portuguese national member organization (NMO)—from 2012 to 2020.
The World Federation of Hemophilia (WFH) would like to congratulate Miguel Crato and wish him all best as president of the EHC.
To learn more about the EHC, please click here.